TG Therapeutics Inc logo

TG Therapeutics Inc

STU:NKB2 (USA)   Ordinary Shares
€ 22.51 (-0.64%) Sep 19
42.13
P/B:
22.04
Market Cap:
€ 3.52B ($ 3.93B)
Enterprise V:
€ 3.43B ($ 3.83B)
Volume:
-
Avg Vol (2M):
1.49K
Trade In:

TG Therapeutics Inc Valuation Measures